BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 2323360)

  • 1. Vaccine prophylaxis of abattoir-associated Q fever: eight years' experience in Australian abattoirs.
    Marmion BP; Ormsbee RA; Kyrkou M; Wright J; Worswick DA; Izzo AA; Esterman A; Feery B; Shapiro RA
    Epidemiol Infect; 1990 Apr; 104(2):275-87. PubMed ID: 2323360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccine prophylaxis of abattoir-associated Q fever.
    Marmion BP; Ormsbee RA; Kyrkou M; Wright J; Worswick D; Cameron S; Esterman A; Feery B; Collins W
    Lancet; 1984 Dec; 2(8417-8418):1411-4. PubMed ID: 6151039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccine prophylaxis of Q fever. A follow-up study of the efficacy of Q-Vax (CSL) 1985-1990.
    Ackland JR; Worswick DA; Marmion BP
    Med J Aust; 1994 Jun; 160(11):704-8. PubMed ID: 8202006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized, controlled, double-blind, cross-over, clinical trial of Q fever vaccine in selected Queensland abattoirs.
    Shapiro RA; Siskind V; Schofield FD; Stallman N; Worswick DA; Marmion BP
    Epidemiol Infect; 1990 Apr; 104(2):267-73. PubMed ID: 2182329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Markers of cell-mediated immunity after vaccination with an inactivated, whole-cell Q fever vaccine.
    Izzo AA; Marmion BP; Worswick DA
    J Infect Dis; 1988 Apr; 157(4):781-9. PubMed ID: 3346570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Q fever vaccination in Queensland abattoirs.
    Bell M; Patel M; Sheridan J
    Commun Dis Intell; 1997 Feb; 21(3):29-31. PubMed ID: 9079588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abattoir-associated Q fever: a Q fever outbreak during a Q fever vaccination program.
    Gilroy N; Formica N; Beers M; Egan A; Conaty S; Marmion B
    Aust N Z J Public Health; 2001 Aug; 25(4):362-7. PubMed ID: 11529620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Q-Vax Q fever vaccine failures, Victoria, Australia 1994-2013.
    Bond KA; Franklin LJ; Sutton B; Firestone SM
    Vaccine; 2017 Dec; 35(51):7084-7087. PubMed ID: 29132996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effectiveness of Coxiella burnetii vaccines in occupationally exposed populations: a systematic review and meta-analysis.
    O'Neill TJ; Sargeant JM; Poljak Z
    Zoonoses Public Health; 2014 Mar; 61(2):81-96. PubMed ID: 23721172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and immunogenicity in human volunteers of a chloroform-methanol residue vaccine for Q fever.
    Fries LF; Waag DM; Williams JC
    Infect Immun; 1993 Apr; 61(4):1251-8. PubMed ID: 8454328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Guinea pig abscess/hypersensitivity model for study of adverse vaccination reactions induced by use of Q fever vaccines.
    Wilhelmsen CL; Waag DM
    Comp Med; 2000 Aug; 50(4):374-8. PubMed ID: 11020154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Limited humoral and cellular responses to Q fever vaccination in older adults with risk factors for chronic Q fever.
    Schoffelen T; Herremans T; Sprong T; Nabuurs-Franssen M; Wever PC; Joosten LA; Netea MG; van der Meer JW; Bijlmer HA; van Deuren M
    J Infect; 2013 Dec; 67(6):565-73. PubMed ID: 23973626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Experience in vaccinating farm animals for preventing Q fever in humans].
    Lisák V
    Tr Inst Im Pastera; 1989; 66():143-53, 174. PubMed ID: 2485300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of a killed phase I Coxiella burnetii vaccine in cynomolgus monkeys (Macaca fascicularis).
    Kishimoto RA; Gonder JC; Johnson JW; Reynolds JA; Larson EW
    Lab Anim Sci; 1981 Feb; 31(1):48-51. PubMed ID: 7253550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seroprevalence of Q fever among metropolitan and non-metropolitan blood donors in New South Wales and Queensland, 2014-2015.
    Gidding HF; Faddy HM; Durrheim DN; Graves SR; Nguyen C; Hutchinson P; Massey P; Wood N
    Med J Aust; 2019 Apr; 210(7):309-315. PubMed ID: 30848517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spatial, temporal, and occupational risks of Q fever infection in South Australia, 2007-2017.
    Rahaman MR; Milazzo A; Marshall H; Bi P
    J Infect Public Health; 2020 Apr; 13(4):544-551. PubMed ID: 31706842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Q fever cluster among workers at an abattoir in south-western Sydney, Australia, 2015.
    Lord H; Fletcher-Lartey S; Weerasinghe G; Chandra M; Egana N; Schembri N; Conaty S
    Western Pac Surveill Response J; 2016; 7(4):21-27. PubMed ID: 28246578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Initial clinical and immunologic evaluation of a new phase I Q fever vaccine and skin test in humans.
    Ascher MS; Berman MA; Ruppanner R
    J Infect Dis; 1983 Aug; 148(2):214-22. PubMed ID: 6350491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody responses in acute and chronic Q fever and in subjects vaccinated against Q fever.
    Worswick D; Marmion BP
    J Med Microbiol; 1985 Jun; 19(3):281-96. PubMed ID: 2409285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Q fever vaccine uptake in South Australian meat processors prior to the introduction of the National Q Fever Management Program.
    Milazzo A; Featherstone KB; Hall RG
    Commun Dis Intell Q Rep; 2005; 29(4):400-6. PubMed ID: 16465932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.